AusCann Group Holdings (ASX:AC8) (OTC:ACNNF) is in the business of manufacturing and distributing medical marijuana in Australia.

AusCann is one of few companies with a license to manufacture medical marijuana, making it extremely valuable. Yesterday's interview with Elaine Darby, Managing Director at AusCann, shed some light on the company's partnership with Tasmania Alkaloids, Canopy Growth Corp. (TSX:WEED) (OTC:TWMJF) and more.

Related: Marijuana Stocks Listed on the ASX

Formerly owned by Johnson & Johnson (NYSE:JNJ), Tasmania Alkaloids is one of the worlds largest producers of opioids. As for AusCann's partnership with Canopy, the company currently imports medical marijuana from Canopy Growth Corp, a major Canadian Licensed Producer. Darby expects the Australian market to take off at a more rapid rate that Canada's given how much they've been able to learn from their North American counterparts.

For more ASX-listed marijuana stocks, check out our Australian marijuana stock database. Be sure to subscribe to one or more of our free newsletters so you never miss an important marijuana stock update. Also, don't forget to connect with The Daily Marijuana Observer on social media via Facebook, Twitter, StockTwits, and Instagram.

D/M/O